Search

Your search keyword '"Steyer, Elisabeth"' showing total 22 results
Start Over Author "Steyer, Elisabeth"
22 results on '"Steyer, Elisabeth"'

2. Recommandations sur la mesure de la pression artérielle. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie

Author

Asmar, Roland, Boivin, Jean-Marc, Girerd, Xavier, Le Jeune, Sylvain, Vaisse, Bernard, Antakly-Hanon, Yara, Artifoni, Mathieu, Atallah, André, Bachelet, Christophe, Barber-Chamoux, Nicolas, Bejan-Angoulvant, Theodora, Blacher, Jacques, Boulestreau, Romain, Chantrel, François, Dimitrov, Yves, Doll, Gérard, Dugelay, Giselle, Duly-Bouhanick, Béatrice, Gosse, Philippe, Guerrot, Dominique, Jarraya, Faiçal, Lamirault, Guillaume, Lequeux, Benoit, Lopez-Sublet, Marilucy, Mercier, Alain, Millet, Laurène, Mounier-Véhier, Claire, Mourad, Jean-Jacques, Nasr, Edgar, Ormezzano, Olivier, Perez, Laurence, Persu, Alexandre, Ribstein, Jean, Silhol, François, Sosner, Philippe, Steyer, Elisabeth, Temmar, Mohamed, Van De Borne, Philippe, Vidal-Petiot, Emmanuelle, and Denolle, Thierry

Published
2019
Full Text
View/download PDF

4. [Expert consensus statement on blood pressure measurement from the French Society of Hypertension, an affiliate of the French Society of Cardiology]

Author

Denolle, Thierry, Asmar, Roland, Boivin, Jean-Marc, Girerd, Xavier, Le Jeune, Sylvain, Vaisse, Bernard, Antakly-Hanon, Yara, Artifoni, Mathieu, Atallah, André, Bachelet, Christophe, Barber-Chamoux, Nicolas, Bejan-Angoulvant, Theodora, Blacher, Jacques, Boulestreau, Romain, Chantrel, François, Dimitrov, Yves, Doll, Gérard, Dugelay, Giselle, Duly-Bouhanick, Béatrice, Gosse, Philippe, Guerrot, Dominique, Jarraya, Faiçal, Lamirault, Guillaume, Lequeux, Benoît, Lopez-Sublet, Marilucy, Mercier, Alain, Millet, Laurène, Mounier-Vehier, Claire, Mourad, Jean-Jacques, Nasr, Edgar, Ormezzano, Olivier, Perez, Laurence, Persu, Alexandre, Ribstein, Jean, Silhol, François, Sosner, Philippe, Steyer, Elisabeth, Temmar, Mohamed, Van De Borne, Philippe, Vidal-Petiot, Emmanuelle, Service de cardiologie et maladies vasculaires [CHU de Rennes], CHU Pontchaillou [Rennes], Département de médecine générale [Univ. Lorraine], Université de Lorraine (UL), Service d'endocrinologie-métabolisme [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Hôpital de la Timone [CHU - APHM] (TIMONE), Service de médecine interne [Nantes], Université de Nantes (UN)-Hôtel-Dieu-Centre hospitalier universitaire de Nantes (CHU Nantes), Service de cardiologie, Centre Hospitalier de la Basse Terre, CIC 501, Centre d’Investigation Clinique (CIC), Service de Pharmacologie Clinique, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Equipe 3: EREN- Equipe de Recherche en Epidémiologie Nutritionnelle (CRESS - U1153), Université Paris 13 (UP13)-Institut National de la Recherche Agronomique (INRA)-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC), Université de Bordeaux (UB), Centre Hospitalier Emile Muller [Mulhouse] (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA), Hôpital Saint-André, Service de Néphrologie [Rouen], Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU), Endothélium, valvulopathies et insuffisance cardiaque (EnVI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU), unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Service de cardiologie [CHU de Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Institut français de l'Education (IFÉ), École normale supérieure - Lyon (ENS Lyon), Hôpital cardiologique, Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital avicenne, Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Avicenne, Clinique Cardiologie et Hypertension Artérielle, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-Hôpital Michallon, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Laboratoire 'Mobilité, Vieillissement, Exercice' (MOVE) (MOVE), Université de Poitiers, Cabinet médical, Centre d'Investigations Préventives et Cliniques (CIPC), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-hôpital Jean-Verdier, Department of Cardiology, Erasme University Hospital, Paris-Centre de Recherche Cardiovasculaire (PARCC - UMR-S U970), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], Société française d’hypertension artérielle (SFHTA), Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Clermont-Ferrand, Université de Tours (UT), Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA), Centre hospitalier de Haguenau, CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Sfax - University of Sfax, Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Avicenne [AP-HP], Cliniques Universitaires Saint-Luc [Bruxelles], Hôpital Erasme [Bruxelles] (ULB), Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Université de Tours, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Hôpital Européen Georges Pompidou [APHP] (HEGP), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Consensus, Time Factors, Hypertension, Humans, Blood Pressure Determination, France, Blood Pressure Monitoring, Ambulatory, Societies, Medical, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience; Since 2016, the French Society of Hypertension has warned about the decline in the management of high blood pressure in France: stagnation, or even decreased number of people who know their blood pressure level, take a treatment and are controlled. These results are lower than those observed in many other countries. Blood pressure is measured with an old method in the doctor's office. Accepted, simple and cost-effective, this method is currently unavoidable for reasons of feasibility and social habit. It has been used in observational and intervention studies that are the basis of the medical reasoning for screening, treatment and drug control of hypertension. In practice, it is too often poorly applied and unpredictable. It is now necessary to measure blood pressure in mmHg using a validated oscillometric automatic device coupled to a specific upper arm cuff adapted to the arm circumferences for the diagnosis and monitoring of high blood pressure in the doctor's office and at home. The auscultatoric measurement is only recommended if any doubt about the reliability of the electronic measurement. Blood pressure measurement is basically performed on both arms to detect asymmetry and then on the arm with the highest blood pressure. It is performed in sitting or lying position after a few minutes of rest without speaking and without having smoked and then in standing position to diagnose orthostatic hypotension, especially in elderly, diabetic and multi-medicated subjects. The blood pressure measurement during the consultation must be repeated and include at least 3 consecutive measurements at one minute intervals. The average of the last 2 measurements determines the blood pressure level. It is recommended to perform BP measurements outside the medical environment for the diagnosis and monitoring of hypertension; Home BP measurement is preferred to ambulatory blood pressure measurement for practical reasons unless otherwise specified. The home blood pressure measurement should include three measurements in the morning at breakfast and three measurements in the evening before bedtime at one minute intervals for at least three days. Prior training must be provided. In treated hypertensive patients, a masked hypertension should be considered as an uncontrolled hypertension and antihypertensive therapy adapted accordingly. The measurement of central BP pressure (aorta) should be limited to clinical research.

Published
2019

6. The effect of ceramic reinforced polyether‐ether‐ ketone (PEEK) abutments on peri‐implant tissues: a randomized controlled clinical trial – preliminary data

Author

Koller, Martin, primary, Sprinz, Alexander, additional, Francisco, Helena, additional, Chen, Andre, additional, Steyer, Elisabeth, additional, Theisen, Kerstin, additional, Sokolowski, Alwin, additional, Arefnia, Behrouz, additional, Jakse, Norbert, additional, and Payer, Michael, additional

Published
2020
Full Text
View/download PDF

9. Recommandations sur la mesure de la pression artérielle. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie

Author

Denolle, Thierry, primary, Asmar, Roland, additional, Boivin, Jean-Marc, additional, Girerd, Xavier, additional, Le Jeune, Sylvain, additional, Vaisse, Bernard, additional, Antakly-Hanon, Yara, additional, Artifoni, Mathieu, additional, Atallah, André, additional, Bachelet, Christophe, additional, Barber-Chamoux, Nicolas, additional, Bejan-Angoulvant, Theodora, additional, Blacher, Jacques, additional, Boulestreau, Romain, additional, Chantrel, François, additional, Dimitrov, Yves, additional, Doll, Gérard, additional, Dugelay, Giselle, additional, Duly-Bouhanick, Béatrice, additional, Gosse, Philippe, additional, Guerrot, Dominique, additional, Jarraya, Faiçal, additional, Lamirault, Guillaume, additional, Lequeux, Benoit, additional, Lopez-Sublet, Marilucy, additional, Mercier, Alain, additional, Millet, Laurène, additional, Mounier-Véhier, Claire, additional, Mourad, Jean-Jacques, additional, Nasr, Edgar, additional, Ormezzano, Olivier, additional, Perez, Laurence, additional, Persu, Alexandre, additional, Ribstein, Jean, additional, Silhol, François, additional, Sosner, Philippe, additional, Steyer, Elisabeth, additional, Temmar, Mohamed, additional, Van De Borne, Philippe, additional, and Vidal-Petiot, Emmanuelle, additional

Published
2019
Full Text
View/download PDF

10. Symptômes dépressifs de l’adolescent et médecine générale

Author

Chau, Kenora, Morin, Samuel, Steyer, Elisabeth, Di Patrizio, Paolo, Boivin, Jean-Marc, Di Patrizio, Paolo, and Université de Lorraine (UL)

Subjects
[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, [SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2018

14. Violences entre partenaires intimes : repérer et prendre en charge.

Author

Scali, Claude, Huez-Robert, Marie Françoise, Dumoulin, Marc, Bergua, Gérard, Steyer, Elisabeth, and Le Noc, Yves

Subjects
INTIMATE partner violence, DOMESTIC violence, PUBLIC health, CRIME victims
Abstract

Résumé: Les violences conjugales (VC) sont un phénomène d'ampleur bien reconnu et constituent en France un véritable enjeu de santé publique. En 2019 selon un rapport du ministère de l'intérieur 173 faits de morts violentes au sein du couple ont été recensés, contre 149 en 2018 (+16 %). Ainsi, un décès criminel survient au sein du couple tous les deux jours et demi et une femme décède sous les coups de son partenaire ou de son ex-partenaire tous les trois jours. Ces faits représentent 20 % des 850 homicides et violences volontaires ayant entraîné la mort sans intention de la donner enregistrés en France en 2019. De très nombreuses associations et les pouvoirs publics sont mobilisés pour venir en aide aux victimes. Une nouvelle loi a été votée en Juillet 2020 visant à protéger les victimes de violences conjugales ; elle peut participer à une meilleure prise en charge de ces violences. Cependant, le repérage des VC reste encore à ce jour insuffisant. Une minorité de femmes évoquent spontanément les violences subies. Le médecin généraliste est l'un de leurs premiers interlocuteurs. Son rôle est essentiel dans le dépistage, l'information et l'orientation pour les aider activement à organiser leur sécurité, à composer avec la violence et à prendre des mesures pour la réduire. Domestic violence (IP) is a widely recognized phenomenon and constitutes a real public health issue in France. In 2019, according to a report from the Ministry of the Interior, 173 incidents of violent death within the couple were recorded, against 149 in 2018 (+16%). Thus, a criminal death occurs within the couple every two and a half days and a woman dies under the blows of her partner or her ex-partner every three days. These facts represent 20 % of the 850 homicides and intentional violence that resulted in death without intention of giving it recorded in France in 2019. Numerous associations and public authorities are mobilized to come to the aid of the victims. A new law was passed in July 2020 aimed at protecting victims of domestic violence; it can participate in better management of this violence. However, the identification of VCs is still insufficient to this day. A minority of women spontaneously evoke the violence suffered. The general practitioner is one of their first contacts. Its role is essential in screening, information and referral to actively help them organize their safety, cope with violence and take action to reduce it. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

15. All-ceramic restoration of zirconia two-piece implants u00f1 a randomized controlled clinical pilot trial - results of up to 80 months

Author

Steyer, Elisabeth

Abstract

Background In spite of lacking evidence for advantages of substitutes over titanium, it seems that there is a basic movement of patients and dentists toward the use of metal free solutions also in implant dentistry. This tendency is strongly supported by of a growing cohort of patients with concerns over titanium sensitivity, allergies or intolerances irrespective of only weak evidence for clinical relevance as well as clinical concerns regarding aesthetic outcomes in the anterior region.Aim/Hypothesis The aim of this study was to evaluate the outcomes of all-ceramic crowns on two-piece zirconia implants in a prospective randomized controlled study after up to 80 monthsMaterials and Methods 21 patients with a total of 28 implants (14 zirconia and 14 titanium) were reviewed up to 80 months following restoration. Bleeding on probing (BOP), plaque index (PI), pink aesthetic score (PES), mean radiographic marginal bone resorption, and implant survival was determined.Results After a mean observation time of 80.9 months (SD u00b1 5.5) the following data were assessed: Mean marginal bone level of -1.38mm at zirconia (SD u00b1 0.81) and -1.17mm at titanium implants (SD u00b1 0.73). BOP of 16.43% (SD u00b1 6.16) at zirconia and 12.60% (SD u00b1 7.66) at titanium implants. PI of 11.07% (SD u00b1 8.11) at zirconia and 15.20 % (SD u00b1 15.58) at titanium implants. PES of 11.38 (SD u00b1 0.92) at zirconia and 11.56 (SD u00b1 1.01) at titanium implants respectively. Two zirconia implants and 1 titanium were lost within the evaluated period after implant surgery resulting in a survival rate of 85.7% for zirconia and 93.3% for titanium implants.Conclusions and Clinical Implications In the present pilot trial no significant differences between adhesively luted zirconia abutments and all-ceramic restorations on two-piece zirconia implants could be observed after up to 80 months compared to a titanium control group. The small study population needs to be taken in consideration when interpreting the results.

Published
2017

16. COVID-19 : pourquoi les masques ?

Author

Drahi, Éric, Huez-Robert, Marie Françoise, Dumoulin, Marc, Bergua, Gérard, Scali, Claude, Steyer, Elisabeth, and Le Noc, Yves

Subjects
COVID-19, MEDICAL masks, SARS-CoV-2, SNEEZING, COUGH
Abstract

Résumé: Le SARS-CoV-2, responsable de la maladie COVID-19, est un virus très contagieux qui se propage principalement par contact étroit avec des personnes infectées. L'OMS recommande de ne pas porter systématiquement de masques en milieu communautaire en raison du manque de preuves. Les masques sont très communément utilisés, indépendamment même de tout contexte épidémique, dans les pays d'Asie. La France, après plusieurs hésitations et des avis divergeants, notamment de l'Académie de Médecine, recommande, au moment du déconfinement, comme d'autres pays, le port large du masque dans l'espace publique et au sein du foyer en cas de personne malade. Quelques questions se posent à propos de l'efficacité de ces mesures ? SARS-CoV-2, which causes COVID 19 disease, is a highly contagious virus that is spread mainly through close contact with infected people. The WHO recommends that community masks should not be worn systematically due to the lack of evidence. Masks are very commonly used, regardless of any epidemic context, in Asian countries. France, after several hesitations and diverging opinions, in particular from the Academy of Medicine, recommends, at the time of deconfinement, like other countries, the wide wearing of the mask in public space and within the home in case of sick person. Are there any questions about the effectiveness of these measures ? [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

17. Ateliers cliniques de perfectionnement en séméiologie clinique, une expérience auprès d’internes en stage ambulatoire

Author

MILLET-MALLINGREY, Laurène, MAUFFREY-BRUNELLI, Violaine, Di Patrizio, Paolo, Steyer, Elisabeth, Boivin, Jean-Marc, Di Patrizio, Paolo, and Université de Lorraine (UL)

Subjects
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2013

18. Les tests de concordance de script pour l’évaluation des internes de médecine générale. Une expérience en ligne entre la Faculté de Médecine de Nancy et l’Université de Montréal

Author

Aubrège, Alain, Boivin, Jean-Marc, Steyer, Elisabeth, ADAM, Jean-Louis, Raphael, Francis, Di Patrizio, Paolo, Kohler, François, Charlin, Bernard, De Korwin, Jean-Dominique, Université de Lorraine (UL), and Di Patrizio, Paolo

Subjects
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2010

19. Perceptions et attitudes envers les benzodiazépines chez les 18-55 ans.

Author

Zbitou, Afif and Steyer, Elisabeth

Abstract

Addictive behaviors and dependence on benzodiazepines have been the subject of extensive research, mainly in young adults and adolescents. The effects produced, and in particular the deleterious effects in the senior (falls, cognitive impairment) have been widely studied. The use of these therapies in the age groupof18 to55 appears different from that observed in those more than 50 years old, but there has been more limited work on this last group. This article presents a qualitative exploratory study on psychological and anthropological perspective, by focusing on the modes of personal use of benzodiazepines byworkingageadults. The main objective is to collect representations and attitudes towards the benzodiazepines prescribed to participants. It offers the practitioner an overview of the patient's intrinsic reflection in its singular use of prescribed medication, outside the framework of the consultation. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

20. Contribution of clinical tests to the diagnosis of rotator cuff disease: A systematic literature review

Author

Beaudreuil, Johann, primary, Nizard, Rémy, additional, Thomas, Thierry, additional, Peyre, Mireille, additional, Liotard, Jean Pierre, additional, Boileau, Pascal, additional, Marc, Thierry, additional, Dromard, Catherine, additional, Steyer, Elisabeth, additional, Bardin, Thomas, additional, Orcel, Philippe, additional, and Walch, Gilles, additional

Published
2009
Full Text
View/download PDF

21. Infections virales respiratoires : quels masques pour la protection des personnels de santé ?

Author

Steyer, Elisabeth, Huez-Robert, Marie Françoise, Dumoulin, Marc, Bergua, Gérard, Scali, Claude, Chorrin-Cagnat, Elisabeth, and Le Noc, Yves

Subjects
*MEDICAL personnel, *MEDICAL care, *INFLUENZA, *SARS disease, *MIDDLE East respiratory syndrome
Abstract

Résumé: Quelques études ont été effectuées sur l'efficacité des mesures barrière pour la protection des professionnels de santé au contact avec des patients infectés lors d'épidémies de maladies virales à transmission respiratoire comme la grippe saisonnière, le syndrome respiratoire aigu sévère (SRAS) ou le syndrome respiratoire du Moyen-Orient (MERS). Elles permettent plus facilement d'associer le contact contaminant et son effet que les études en population générale. Elles ne gomment pas le fait que lors d'épidémies, les soignants sont soumis dans leur vie extraprofessionnelle aux risques communautaires. Some studies have been carried out on the effectiveness of barrier measures for the protection of healthcare professionals in contact with patients infected during epidemics of viral respiratory diseases such as seasonal influenza, severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS). They make it easier to associate contaminating contact and its effect than studies in the general population. They do not erase the fact that during epidemics, carers are subject in their extra-professional life to community risks. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

22. Émotions en simulation en santé: levier ou frein pour l'apprentissage? Étude qualitative phénoménologique par entretiens semi-dirigés.

Author

GATIN, Amélie, HAUET, Mathilde, BRAUN, Marc, VAROQUI, Claude, KLEFFERT, Jean Michel, HANI, Hind, LACREUSE-TALON, Isabelle, PELACCIA, Thierry, and STEYER, Elisabeth

Abstract

Copyright of Pédagogie Médicale is the property of EDP Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results